{
    "code": "02022820",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022820",
    "time": "2019-12-06 03:22:45",
    "許可證字號": "衛署藥輸字第022820號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/04\/07",
    "發證日期": "89\/04\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202282001",
    "中文品名": "拿塞可得鼻用噴液劑",
    "英文品名": "NASACORT AQ",
    "適應症": "成人之季節性及經年性過敏性鼻炎。",
    "劑型": "404鼻用噴液劑",
    "包裝": "瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1424601100  賽諾菲股份有限公司",
        "申請商地址": "台北市信義區松仁路3號7樓",
        "主製造廠": ""
    },
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FGB0190000  AVENTIS PHARAMA LTD.",
            "製造廠廠址": "RPR HOUSE, 50 KINGS HULL AVENUE, WEST MAILLING, KENT, UNITED KINGDOM, ME19 4AH",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804001610",
            "成分名稱": "TRIAMCINOLONE ACETONIDE",
            "含量描述": "",
            "含量": "0.5500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Nasacort_box & spray-104-09-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022820&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Nasacort AQ - English PI_CCDS v6 (rev) 2017 clean-107-09-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022820&Seq=019&Type=9"
        },
        {
            "title": "Nasacort AQ - Chinese PI (app) CCDS v6-Sep-2017_HA comments clean-107-09-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022820&Seq=018&Type=9"
        },
        {
            "title": "Nasacort AQ label (1060815)-106-09-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022820&Seq=004&Type=8"
        },
        {
            "title": "1060317-NASACORT AQ Box-106-09-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022820&Seq=003&Type=8"
        }
    ]
}